10-K
File 001-38662
10-K
- Filing date
- 23 Mar 2026
- Reporting date
- 31 Dec 2025
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
SUTRO BIOPHARMA, INC. reports
- Location
- South San Francisco, CA
- Fiscal year end
- 31 December
Company identity
SEC reporting
SUTRO BIOPHARMA, INC. has filed 608 SEC EDGAR filings since 08 Nov 2006
SEC filing history
Showing 1-9 of 9 matching filings.
Per page
25
Current page
1
10-K
File 001-38662
10-K
- Filing date
- 13 Mar 2025
- Reporting date
- 31 Dec 2024
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K
File 001-38662
10-K
- Filing date
- 25 Mar 2024
- Reporting date
- 31 Dec 2023
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K
File 001-38662
10-K
- Filing date
- 30 Mar 2023
- Reporting date
- 31 Dec 2022
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K
File 001-38662
10-K
- Filing date
- 28 Feb 2022
- Reporting date
- 31 Dec 2021
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K
File 001-38662
10-K
- Filing date
- 18 Mar 2021
- Reporting date
- 31 Dec 2020
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K/A
File 001-38662
10-K/A
- Filing date
- 04 May 2020
- Reporting date
- 31 Dec 2019
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
10-K
File 001-38662
10-K
- Filing date
- 16 Mar 2020
- Reporting date
- 31 Dec 2019
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing
10-K
File 001-38662
10-K
- Filing date
- 01 Apr 2019
- Reporting date
- 31 Dec 2018
- SEC evidence
- Open document Open filing Open XBRL
- Next action
- Verify source filing